Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gaye Jenkins"'
Autor:
Denise Niewerth, Gertjan J. L. Kaspers, Gerrit Jansen, Johan van Meerloo, Sonja Zweegman, Gaye Jenkins, James A. Whitlock, Stephen P. Hunger, Xiaomin Lu, Todd A. Alonzo, Peter M. van de Ven, Terzah M. Horton, Jacqueline Cloos
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-9 (2016)
Abstract Background Drug combinations of the proteasome inhibitor bortezomib with cytotoxic chemotherapy are currently evaluated in phase 2 and 3 trials for the treatment of paediatric acute myeloid leukaemia (AML) and acute lymphocytic leukaemia (AL
Externí odkaz:
https://doaj.org/article/172eb78a2bea491c981a5e1211f1352f
Autor:
Stacey L. Berg, Madhuri Hegde, Shannon L. Delaney, Susan M. Blaney, Alison A. Bertuch, Albert Ribes-Zamora, M. Eileen Dolan, Linna Zhang, Debananda Pati, Gaye Jenkins, Terzah M. Horton
Supplementary Data from Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e2de24c4989d293cf1dfc473c2af7c
https://doi.org/10.1158/1535-7163.22485192
https://doi.org/10.1158/1535-7163.22485192
Autor:
Stacey L. Berg, Madhuri Hegde, Shannon L. Delaney, Susan M. Blaney, Alison A. Bertuch, Albert Ribes-Zamora, M. Eileen Dolan, Linna Zhang, Debananda Pati, Gaye Jenkins, Terzah M. Horton
The poly(ADP-ribose) polymerase (PARP) inhibitor ABT-888 potentiates the antitumor activity of temozolomide (TMZ). TMZ resistance results from increased O6-methylguanine-DNA methyltransferase (MGMT) activity and from mismatch repair (MMR) system muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f473ded03df0e26c20c0671d598841
https://doi.org/10.1158/1535-7163.c.6531828
https://doi.org/10.1158/1535-7163.c.6531828
Autor:
Jeffery M. Klco, Sherif Abdelhamed, Lina Gao, Gaye Jenkins, Ding-Wen Chen, John T. Butler, Terzah M. Horton, Seul Jung, Peter Kurre, Jeong Y. Lim
Publikováno v:
Blood Advances
Key Points Candidate discovery of translational feasibility for noninvasive measurement of miRNA from plasma vesicles as a biomarker for AML patients.Preclinical validation of miR-1246 (candidate among 15 miRNA) as a potential minimally invasive AML
Autor:
Margot S.F. Roeten, Johan van Meerloo, Zinia Kwidama, Gaye Jenkins, Suzanne N. van Dijk, David T. Teachey, Meenakshi Devidas, Mignon L. Loh, Gertjan J.L. Kaspers, Sonja Zweegman, Gerrit Jansen, Jacqueline Cloos, Terzah M. Horton
Publikováno v:
Blood. 140:9183-9184
Autor:
Fieke W Hoff, Lourdes Sriraja, Yihua Qiu, Gaye Jenkins, Andrew Ligeralde, David T. Teachey, Brent L. Wood, Meenakshi Devidas, Mignon L. Loh, Todd A. Alonzo, Amina A Qutub, Evangelia Petsalaki, Steven M. Kornblau, Terzah M. Horton
Publikováno v:
Blood. 140:6352-6353
Autor:
Todd A. Alonzo, Sophia W.M. Bruggeman, Richard Aplenc, Anneke D. van Dijk, Steven M. Kornblau, E. Anders Kolb, Fieke W Hoff, Eveline S. J. M. de Bont, Amanda R. Leonti, Robert B. Gerbing, Peter P. Ruvolo, Soheil Meshinchi, Yihua Qiu, Alan S. Gamis, Gaye Jenkins, Terzah M. Horton
Publikováno v:
Blood
Blood, 137(8), 1050-1060. AMER SOC HEMATOLOGY
Blood, 137(8), 1050-1060. AMER SOC HEMATOLOGY
Bortezomib (BTZ) was recently evaluated in a randomized phase 3 clinical trial by the Children’s Oncology Group (COG) that compared standard chemotherapy (cytarabine, daunorubicin, and etoposide [ADE]) vs standard therapy with BTZ (ADEB) for de nov
Autor:
Todd A. Alonzo, Terzah M. Horton, Fieke W Hoff, Alan S. Gamis, Gaye Jenkins, Eveline S. J. M. de Bont, Soheil Meshinchi, Anneke D. van Dijk, Yihua Qiu, Richard Aplenc, Steven M. Kornblau, Robert B. Gerbing, E. Anders Kolb
Publikováno v:
Proteomics Clin Appl
Proteomics-Clinical Applications, 16(2):2100072. WILEY-V C H VERLAG GMBH
Proteomics-Clinical Applications, 16(2):2100072. WILEY-V C H VERLAG GMBH
Purpose: The addition of the proteasome inhibitor (PI) bortezomib to standard chemotherapy (ADE: cytarabine [Ara-C], daunorubicin, and etoposide) did not improve overall outcome of pediatric AML patients in the Children's Oncology Group AAML1031 phas
Autor:
Debra J. Morrison, Anneke D. van Dijk, Gaye Jenkins, Teena Bhatla, Julia Meyer, Steven M. Kornblau, Laura Hogan, Terzah M. Horton, Qianxing Mo, Yihua Qiu, Eleny Romanos-Sirakis, William L. Carroll, Fieke W Hoff, Tao Wang
Publikováno v:
J Proteomics
Journal of proteomics, 233:104046. ELSEVIER SCIENCE BV
Journal of proteomics, 233:104046. ELSEVIER SCIENCE BV
Reverse phase protein arrays (RPPA) can assess protein expression and activation states in large numbers of samples (n>1000) and evidence suggests feasibility in the setting of multi-institution clinical trials. Despite evidence in solid tumors, litt
Autor:
Terzah M. Horton, Gaye Jenkins, Hema Dave, D Saunders, Sharon M. Castellino, Qinglin Pei, M Mai, Frank G. Keller, Kara M. Kelly, C Bollard
Publikováno v:
Klinische Pädiatrie.